Clinical trials
Phase 3 Disorders of Excessive Somnolence trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 3 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alkermes, Inc. | 3 |
| Axsome Therapeutics, Inc. | 3 |
| Cephalon | 3 |
| Avadel | 2 |
| Harmony Biosciences Management, Inc. | 2 |
| Orphan Medical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disorders of Excessive Somnolence | 14 |
| Narcolepsy | 8 |
| Cataplexy | 6 |
| Sleep Wake Disorders | 4 |
| Fatigue | 2 |
| Sleep Apnea, Obstructive | 2 |
| Idiopathic Hypersomnia | 1 |
| Parasomnias | 1 |
| Prader-Willi Syndrome | 1 |
| Sleep Disorders, Circadian Rhythm | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.